Navigation Links
Amicus Therapeutics to Present at Jefferies 2011 Global Healthcare Conference on Tuesday, June 7, 2011
Date:5/31/2011

CRANBURY, N.J., May 31, 2011 /PRNewswire/ -- Amicus Therapeutics (Nasdaq: FOLD) today announced that Matthew R. Patterson, President and Acting Chief Executive Officer, will present a corporate overview at the Jefferies 2011 Global Healthcare Conference in New York, NY on Tuesday, June 7 at 12:15 p.m. ET.

A live webcast of the presentation can be accessed through the Investors section of the Amicus Therapeutics corporate web site at http://ir.amicustherapeutics.com/events.cfm, and will be archived for 90 days. Participants are encouraged to visit the web site 10 minutes prior to the start of the presentation to register, download and install any necessary software.

About Amicus Therapeutics

Amicus Therapeutics (Nasdaq: FOLD) is a biopharmaceutical company at the forefront of developing therapies for rare diseases. The Company is developing orally-administered, small molecule drugs called pharmacological chaperones, a novel, first-in-class approach to treating a broad range of diseases including lysosomal storage disorders and diseases of neurodegeneration. Amicus' lead program Amigal(tm) (migalastat HCl) is in Phase 3 for the treatment of Fabry disease.

FOLD-G


'/>"/>
SOURCE Amicus Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Amicus Therapeutics Announces First Quarter 2011 Financial Results and Continued Progress of Development Programs
2. Amicus Therapeutics Announces Transition of John F. Crowley from Chairman and Chief Executive Officer to Executive Chairman
3. Amicus Therapeutics Announces FDA Agreement to Commence Phase 2 Study of AT2220 Co-administered with Enzyme Replacement Therapy for Pompe Disease
4. Amicus Therapeutics Initiates Phase 2 Clinical Trial Evaluating Amigal™ Co-administered with Enzyme Replacement Therapy
5. Amicus Therapeutics to Present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011
6. Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinsons Disease
7. Amicus Therapeutics Announces Third Quarter 2010 Financial Results
8. GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease
9. Amicus Therapeutics to Host Conference Call and Webcast to Discuss Exclusive Worldwide Agreement with GSK to Develop and Commercialize Amigal™ for Fabry Disease
10. Amicus Therapeutics to Host Its Second Quarter 2010 Financial Results Conference Call and Webcast on August 5, 2010
11. Amicus CEO Represents BIO on Rare Diseases at U.S. Senate Committee on Health, Education, Labor and Pensions Bipartisan Hearing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015 For the pharmaceutical industry, marketplace ... with payers. Likewise, the importance of the managed markets function ... continue to grow as payer formularies and provider networks play ... At the same time, managed markets leaders must continually ...
(Date:1/23/2015)... Jan. 23, 2015  The Partnership to Fight Chronic Disease (PFCD) released ... care leaders and a new study analyzing the impact of increased ... a nationwide coalition working to educate policy makers and the public ... Capitol was focused on how the Iowa ...
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. today ... Inc. for the compounding, packaging and distributing of its naltrexone ... the United States . KRS ... compounding naltrexone tablets in various strengths for individual patients in ...
Breaking Medicine Technology:As Payer Influence Rises, Pharmaceutical Companies work to Optimize the Managed Markets Function 2New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4
... (NASDAQ: DCTH ) today announced the Therapeutic ... approved the Delcath Hepatic CHEMOSAT® Delivery system for listing ... TGA,s approval allows Delcath to market and sell the ... Australia represents another achievement for Delcath as we seek ...
... Feb. 14, 2012  Intellect Neurosciences, Inc. (OTCBB: ILNS), ... development of disease-modifying therapeutic agents for the treatment ... that it submitted a statement setting out its ... preliminary decision to revoke the company,s ANTISENILIN® patents ...
Cached Medicine Technology:Delcath Receives Regulatory Approval to Commercialize Hepatic CHEMOSAT® Delivery System in Australia 2Delcath Receives Regulatory Approval to Commercialize Hepatic CHEMOSAT® Delivery System in Australia 3Intellect Neurosciences Submits Statement Setting Grounds for Appeal in European Patent Proceedings 2Intellect Neurosciences Submits Statement Setting Grounds for Appeal in European Patent Proceedings 3Intellect Neurosciences Submits Statement Setting Grounds for Appeal in European Patent Proceedings 4
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne wedding ... revenues in the past three years. Today, the business announces ... According to the sales manager of the company, this is ... 2015. This point can be reflected on the discounted wedding ...
(Date:1/22/2015)... 2015 Payday lending practices in four ... cause financial distress to the states that permit them, ... University’s Center on Race and Wealth. , While they ... payday loans at the same time substantially depress economic ...
(Date:1/22/2015)... JJsHouse.com is a famous dress online store for wedding dresses ... latest collection of wedding dresses , and launches a site-wide ... wedding dress on your big day; the wedding gown is ... wants to find the most suitable wedding dress. Now, we ...
(Date:1/22/2015)... Richmond, VA (PRWEB) January 22, 2015 ... the power at the Science Museum of Virginia. Wicked ... 24. , Wicked Plants unearths 75 poisonous, carnivorous and ... traverse through each room to uncover the biochemical, physical ...
(Date:12/26/2014)... 26, 2014 It is said that nothing ... Today, UWDress.com, the famous wedding dress supplier, shows its ... site-wide cocktail gown promotion. , UWDress.com’s navy cocktail gowns ... they come in high fashion styles. Simple dresses in bright ...
Breaking Medicine News(10 mins):Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2
... improvements and less cell degeneration , , SUNDAY, Feb. ... appears able to slow or stop Alzheimer,s disease in ... The brain,s entorhinal cortex, which supports memory, normally produces ... decrease when Alzheimer,s is present. When researchers injected BDNF ...
... Trust for America,s Health released the following statement after ... cut more than $100 billion from the American Recovery ... the Senate struck a final bargain to strip all ... plan, failing to recognize that this funding would have ...
... pain and swelling , , FRIDAY, Feb. 6 (HealthDay News) ... symptoms in people with rheumatoid arthritis (RA) has been ... study included two postmenopausal women with advanced RA. Researchers ... women,s affected joints. IL-1Ra protein blocks the actions of ...
... Aflac Incorporated,announced today that it is providing expanded detail ... The company has elevated additional ... and Tier 1 perpetual debenture, including CUSIP numbers for ... The company has also,prepared and elevated a frequently asked ...
... Supplies tend to run dangerously short this time of year , , ... gone, and everyone has settled back into regular routines. , But ... this time of the year. , The nation,s blood supply tends ... to a decline in donations. Now that the new year is ...
... with low glycemic index sweeteners and berries to produce a new type ... benefits of berry antioxidants and probiotics are also discussed with comments from ... ... long been regarded as a sweet and sinful indulgence. Everyone knows ...
Cached Medicine News:Health News:Brain Protein May Have Potential Against Alzheimer's 2Health News:Gene Therapy May Ease Rheumatoid Arthritis 2Health News:Aflac Incorporated Provides Added Detail on Perpetual Debenture Holdings 2Health News:Needed: Blood Donations 2Health News:Needed: Blood Donations 3Health News:Losing Weight with Chocolate on Valentine's Day 2
... Choice for Urinary Tract Infection ... Line. A multi-center study was ... potential UTIs. There were 1,887 ... leukocyte and nitrite results of ...
... busy physician's office environment, interruptions ... to timing errors and variability ... are read visually. Studies have ... performed with an instrument, sensitivity ...
Keep your laboratory efficient. And meet your volume needs. When you set the pace with the Clinitek 500 Urine Chemistry Analyzer. Its ready when you are. No warm-up. No calibration. No bells. Just pr...
... These dual pressure sensor ... sampling/slow-speed injection, slow-speed injection/guide wire, ... model SPC-784A for high-speed injection ... side openings and an open-end ...
Medicine Products: